Overweight Dogs in Europe to Benefit from Pfizer U.S. Experience

NEW YORK--(Business Wire)--European vets are about to be given the same powerful medical tool
which has helped U.S. vets manage obese dogs who don't respond to
exercise and diet.

Since Pfizer Animal Health's SLENTROL(TM) was introduced eight
months ago in the U.S., thousands of obese dogs have benefited from
healthier weights and more active lives.

Now, European vets will be able to talk to dog owners about
Slentrol as an additional tool to improve weight loss success with
diet and exercise. "We've set a challenge for European vets to
encourage owners to take a proactive approach and beat the rise of
canine obesity, and to follow the lessons learned and the success of
their veterinary colleagues in the U.S.," said Patrick Loiseau, group
director, Companion Animal Marketing and Technical - Europe, Africa,
Middle East, Pfizer Animal Health.

Pfizer has been focused on helping U.S. veterinarians better
engage their clients in bringing their pets to a healthy weight. Tens
of thousands of U.S. dog owners have used Pfizer's BARC, the Body
Assessment Rating for Canines, available at www.StopCanineObesity.com.

Slentrol is a daily, oral solution, available only through
veterinarians. Slentrol works by decreasing dogs' appetites, making it
easier for their owners to help them develop new, long-term diet and
exercise behaviours.

"We first have to change the owner's behaviour or we have no
chance of helping an obese dog," said Scott McComb, DVM, McQueen Vet
Clinic, Arizona. Dr. McComb is one of the thousands of U.S.
veterinarians who have successfully moved their clients' dogs to a
healthy weight by prescribing Slentrol. "When I talk to them about
diet and exercise, it's probably 95% - 98% unsuccessful. They all
leave here saying 'I'm going to feed less and exercise more' and it's
amazing to me how often that doesn't work," Dr. McComb said. "Pet
owners need to see the benefits of their efforts, see the benefits of
weight loss, or their own behaviours will never change."

European dog owners and veterinarians are looking for solutions to
what is a growing health concern. "Canine obesity is not just a
problem unique to U.S. dogs and their owners. It's global," Loiseau
said. Studies indicate around 25-40% of all dogs are overweight or
obese.

"The frustrations and the lack of results associated with various
diets or attempts at regular exercise are universal to all dogs and
their owners," according to Loiseau. But in Europe, dog owners are
simply failing to take action against excess weight in their pets, he
said.

A Pfizer-sponsored online survey of 1500 pet owners in the UK,
Spain and Germany, recently showed that just 22% of owners had even
tried to get their dog to lose weight.

"One of the biggest problems facing European pet owners is that
they are not aware of how overweight their dog can be," said Andy
Green, Pennard Veterinary Practice, Kent, UK. "They're not aware of
gradual weight gain until they bring their dogs in for check-ups and
see over time how much their dog has gained weight."

Additional facts about Slentrol

Slentrol is not for use in any other animal, including cats.
Veterinarians are urged not to give Slentrol to dogs with liver
disease or dogs that have been taking steroid treatments for a long
time. The most common side effect from Slentrol is vomiting. A few
dogs may develop diarrhea, seem unusually tired or completely stop
eating. Pet owners also are advised that if any of these side effects
last longer than two days their veterinarian should be consulted.
Slentrol should never be taken by people under any circumstances. For
a copy of Slentrol prescribing information and for additional
information on how Slentrol works to stop canine obesity, go to
www.PfizerAH.com/Slentrol.

About Pfizer Animal Health

Pfizer, Inc (NYSE: PFE), the world's largest research-based
biomedical and pharmaceutical company, also is a world leader in
discovering and developing innovative animal vaccines and prescription
medicines. Pfizer Animal Health is dedicated to improving the safety,
quality and productivity of the world's food supply by enhancing the
health of livestock and poultry; and in helping companion animals live
longer and healthier lives. For additional information on Pfizer's
portfolio of animal health products, go to www.PfizerAH.com.

David Bellis
U.K.: +44 (0)20 8399 1184
Db@Garnett-Keeler.com
or
Rick Goulart
U.S.: 212-733-7457
rick.goulart@pfizer.com

Copyright Business Wire 2008